Both in Pharmaceuticals
Design Therapeutics vs Zevra Therapeutics
Over the past year DSGN returned +57.9% and ZVRA returned +0.5%; their daily moves had a correlation of 0.15.
DSGN +57.9% ZVRA +0.5%Growth of $1, one year, split-adjusted
| Metric | DSGN | ZVRA |
|---|---|---|
| Price | $10.34 | $10.26 |
| Market cap | $647.1M | $609.3M |
| Today | +1.87% | +1.58% |
| 1 month | −16.7% | −4.1% |
| 6 months | −22.9% | −3.3% |
| Year to date | +10.2% | +14.5% |
| 1 year | +54.3% | +0.8% |
| Revenue growth (YoY) | — | +53.3% |
| Gross margin | — | 96.2% |
| Net margin | — | 21.2% |
| P/E (TTM) | — | 10.5× |
| Price / sales | — | 4.5× |
| Net cash | $207.4M | $221.6M |
| Dividend yield | — | — |
| Volatility (60d) | 55.2% | 44.3% |
| Short % of float | 21.8% | 10.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).